Cargando…

Landiolol: pharmacology and its use for rate control in atrial fibrillation in an emergency setting

This article provides new insight on landiolol, an ultra-short acting injectable betablocker, recently approved in Europe, with regard to its pharmacokinetic and pharmacodynamic profile, along with its first experience in Caucasian healthy volunteers and patients with atrial fibrillation. Landiolol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Domanovits, Hans, Wolzt, Michael, Stix, Günter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909771/ https://www.ncbi.nlm.nih.gov/pubmed/30188959 http://dx.doi.org/10.1093/eurheartj/sux037

Ejemplares similares

Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction
por: von Haehling, Stephan, et al.
Publicado: (2018)

Landiolol for managing atrial fibrillation in intensive care
por: Rehberg, Sebastian, et al.
Publicado: (2018)

Landiolol for managing post-operative atrial fibrillation
por: Balik, Martin, et al.
Publicado: (2018)

Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients
por: Hariri, Geoffroy, et al.
Publicado: (2021)

Landiolol for managing atrial fibrillation in post-cardiac surgery
por: Fellahi, Jean-Luc, et al.
Publicado: (2018)

Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy
por: Dan, Gheorghe-Andrei
Publicado: (2022)

Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
por: Aoki, Yoshitaka, et al.
Publicado: (2020)

Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation/Atrial Flutter Patients With Chronic Heart Failure　― A Prospective Observational Survey (AF-CHF Landiolol Survey) ―
por: Yamashita, Takeshi, et al.
Publicado: (2020)

Preventive effect of low-dose landiolol on postoperative atrial fibrillation study (PELTA study)
por: Sasaki, Konosuke, et al.
Publicado: (2020)

Excess short-term mortality in noncritical patients with atrial fibrillation presenting to the emergency department
por: Niederdöckl, Jan, et al.
Publicado: (2021)

Landiolol for the prevention of postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis
por: Cafaro, Teresa, et al.
Publicado: (2023)

Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure
por: Shiga, Tsuyoshi
Publicado: (2022)

Perioperative Landiolol Administration reduces Atrial Fibrillation after Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials
por: Sakamoto, Atsuhiro, et al.
Publicado: (2014)

Urgent Control of Rapid Atrial Fibrillation by Landiolol in Patients With Acute Decompensated Heart Failure With Severely Reduced Ejection Fraction
por: Iwahashi, Noriaki, et al.
Publicado: (2019)

Suppression of amiodarone‐induced torsade de pointes by landiolol in a patient with atrial fibrillation‐mediated cardiomyopathy
por: Takahashi, Koji, et al.
Publicado: (2021)

The ABC-Stroke Score Refines Stroke Risk Stratification in Patients With Atrial Fibrillation at the Emergency Department
por: Niederdöckl, Jan, et al.
Publicado: (2022)

Preventive Effect of Intraoperative Landiolol Administration on Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting
por: Osumi, Masahiro, et al.
Publicado: (2014)

Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol
por: Nakanishi, Kazuhiro, et al.
Publicado: (2013)

Beta-Blocker Landiolol Hydrochloride in Preventing Atrial Fibrillation Following Cardiothoracic Surgery: A Systematic Review and Meta-Analysis
por: Hao, Jianqi, et al.
Publicado: (2021)

Hemodynamic and Rhythmologic Effects of Push-Dose Landiolol in Critical Care—A Retrospective Cross-Sectional Study
por: Schnaubelt, Sebastian, et al.
Publicado: (2023)

Prediction of Successful Pharmacological Cardioversion in Acute Symptomatic Atrial Fibrillation: The Successful Intravenous Cardioversion for Atrial Fibrillation (SIC-AF) Score
por: Niederdöckl, Jan Daniel, et al.
Publicado: (2022)

Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension
por: Schroeder, Lukas, et al.
Publicado: (2022)

Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation
por: Niederdöckl, Jan, et al.
Publicado: (2019)

Safety and effective use of landiolol in the ICU
por: Hifumi, Toru, et al.
Publicado: (2014)

Comparison of landiolol and amiodarone for the treatment of new-onset atrial fibrillation after cardiac surgery (FAAC) trial: study protocol for a randomized controlled trial
por: Caspersen, Edouard, et al.
Publicado: (2023)

Association of Intravenous Potassium and Magnesium Administration With Spontaneous Conversion of Atrial Fibrillation and Atrial Flutter in the Emergency Department
por: Cacioppo, Filippo, et al.
Publicado: (2022)

Pharmacologic Management of Atrial Fibrillation: Established and Emerging Options
por: Kalus, James S.
Publicado: (2009)

Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients
por: Koniari, Ioanna, et al.
Publicado: (2022)

Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department()
por: Simon, Alexander, et al.
Publicado: (2017)

Intravenous landiolol for the prevention of atrial fibrillation after aortic root, ascending aorta, and aortic arch surgery: A propensity score-matched analysis
por: Kaminohara, Jun, et al.
Publicado: (2022)

Atrial fibrillation: a risk factor for unfavourable outcome in COVID-19? A case report
por: Schnaubelt, Sebastian, et al.
Publicado: (2020)

Outcome of pharmacological treatment of patients with atrial fibrillation in the emergency room
por: Ivekovic, H, et al.
Publicado: (2003)

Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study
por: Lévy, Samuel, et al.
Publicado: (2020)

Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience
por: Matsui, Yuko, et al.
Publicado: (2019)

Thromboembolic events, bleeding, and drug discontinuation in patients with atrial fibrillation on anticoagulation: a prospective hospital-based registry
por: Königsbrügge, Oliver, et al.
Publicado: (2016)

Study of hemodynamics in patients treated with landiolol in the ICU
por: Imabayashi, T, et al.
Publicado: (2009)

Rate control strategies for atrial fibrillation
por: Alobaida, Muath, et al.
Publicado: (2021)

The Impact of the COVID-19 Pandemic on Incidences of Atrial Fibrillation and Electrical Cardioversion at a Tertiary Care Emergency Department: An Inter- and Intra-year Analysis
por: Schnaubelt, Sebastian, et al.
Publicado: (2020)

Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature
por: Matsuishi, Yujiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9kn7vlgiddi0hp7k9p60v9k1sc